Chimerix reported $88.3M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Alterity Therapeutics Limited AUD 30M 26M Apr/2026
Ardelyx USD 1.42B 89M Dec/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Curis USD 3M 10M Apr/2026
Emergent BioSolutions USD 125M 51M Dec/2023
Gilead Sciences USD 152.28B 14.55B Dec/2025
Glaxosmithkline GBP 99.93B 13.05B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novavax USD 1.09B 316M Dec/2025